A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.

With an FDA decision looming over its first foray into the acute pain space ... healthcare providers perceive pain and its available treatments. One of the contributing surveys was conducted ...

today announced positive top-line results of its Phase 3 study (B2411367) in Japan evaluating the safety and efficacy of EFFEXOR ® (venlafaxine) in adults with generalized anxiety disorder (GAD).

"The bottom line is the two treatments were very similar," Hoge told MedPage Today. "That confirms our first finding, that meditation impacts anxiety pretty much the same as the drug escitalopram." ...

Images have been released of Piccadilly line trains under construction at a ... Work on assembling the first 10 trains for London Underground began in March. They are expected to be in service ...